Listed by the USPTO as VISHNYAKOVA, ELENA VLADIMIROVNA
Tech Center 1600 • Art Units: 1627 1691
This examiner grants 68% of resolved cases
VISHNYAKOVA, ELENA VLADIMIROVNA works in tech center 1600 and art unit 1627. The profile contains 41 resolved cases, with an allowance rate of 68.3% and a median of 1101 days to allowance. The interview lift is 46.6%, indicating a strong positive association between interviews and allowance outcomes in the available record.
The principal company clients are Remix Therapeutics Inc., Tencent Technology (Shenzhen) Company Limited, and Araris Biotech AG. The leading firms are LANDO & ANASTASI, LLP, Anova Law Group, PLLC, and BELL & ASSOCIATES. The limited case volume calls for careful application, but the interview data supports purposeful contact with the examiner when developing a response or negotiating claim scope.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18455578 | IMIDAZO[1,2-a]PYRAZINE OR PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVE AND USE THEREOF | Final Rejection | TENCENT TECHNOLOGY (SHENZHEN) COMPANY LIMITED |
| 18717529 | PHARMACEUTICAL COMBINATION COMPRISING ABEMACICLIB AND A PI3K AND/OR A MTOR INHIBITOR FOR THE TREATMENT OF MANTLE CELL LYMPHOMA | Non-Final OA | Board of Regents, The University of Texas System |
| 18253891 | COMPOSITIONS AND METHODS FOR BLOCKING NEUROPILIN RECEPTOR 1 FOR THE TREATMENT OF PAIN AND PREVENTION OF VIRAL ENTRY | Final Rejection | Arizona Board of Regents on Behalf of the University of Arizona |
| 18277524 | NOVEL COMPOUND AND ORGANIC LIGHT EMITTING DEVICE COMPRISING THE SAME | Non-Final OA | LG CHEM, LTD. |
| 18030518 | MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR | Final Rejection | VERTEX PHARMACEUTICALS INCORPORATED |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy68.3% of resolved applications examined by Elena Vladimirovna Vishnyakova were allowed (41 resolved cases), compared with 35.1% across Art Unit 1627 over the last five years.
This examiner's interview lift is +46.6 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Elena Vladimirovna Vishnyakova took 1,101 days on average from filing to allowance.
Elena Vladimirovna Vishnyakova examines applications in Art Unit 1627 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
